Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer modelling in predicting carcinogenicity

C Ioannides1, D F Lewis, D V Parke

  • 1Division of Toxicology, School of Biological Sciences, University of Surrey, Guildford, UK.

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An improved method to estimate ultrasonic absorption in agar-based gel phantom using thermocouples and MR thermometry.

Ultrasonics·2020
Same author

PP171. Hospitalized preterm mild preeclamptics: Is there a difference in outcomes between isolated or superimposed disease?

Pregnancy hypertension·2015
Same author

Xenobiotic-metabolizing enzyme systems and aging.

Methods in molecular medicine·2012
Same author

Modulation of hepatic cytochrome P450 activity and carcinogen bioactivation by black and decaffeinated black tea.

Environmental toxicology and pharmacology·2011
Same author

Dissimilar tcr v-Beta frequencies in til from different sites of the same tumor.

International journal of oncology·2011
Same author

Common tcr-Beta chain rearrangements in short-term cultured lymphocytes infiltrating ovarian-tumors.

International journal of oncology·2011
Same journal

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Risk of pancreatic cancer in patients with vitamin D deficiency: a retrospective cohort study.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Recommendations for the use of CanRisk for tubo-ovarian cancer risk estimation: a focus group and Research ANd Development-modified Delphi-based study.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Sociodemographic factors predicting preference for human papillomavirus self-sampling in cervical cancer screening: comparison of opt-out and opt-in strategies.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

The European Cancer Prevention Organization celebrates 45 years of advancing progress in cancer prevention.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same journal

Effectiveness of palliative care in managing adverse reactions in cancer patients: a systematic review and meta-analysis.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
See all related articles

Cytochrome P450 enzymes (CYP) activate chemicals into toxic intermediates. COMPACT and ENACT methods rapidly screen chemicals for toxicity and carcinogenicity, reducing the need for lengthy rodent bioassays.

Area of Science:

  • Biochemistry
  • Toxicology
  • Computational Chemistry

Background:

  • Cytochrome P450 (CYP) enzymes are crucial for metabolizing xenobiotics.
  • CYP1A and CYP2E families activate planar and small molecular weight compounds, respectively, into toxic intermediates.
  • Chemicals interacting with cellular components can cause toxicity and carcinogenicity.

Purpose of the Study:

  • To develop and evaluate a computational method (COMPACT) for predicting chemical interaction with CYP1A and CYP2E.
  • To assess the utility of short-term animal studies (ENACT) for determining chemical induction of CYP enzymes.
  • To establish a rapid and cost-effective preliminary screening strategy for chemical carcinogenicity.

Main Methods:

  • Development of the COMPACT (Computergraphic Prediction of Chemical-CYP Interaction) procedure.

Related Experiment Videos

  • COMPACT analyzes molecular shape and electronic structure to predict CYP1A/CYP2E interaction.
  • ENACT (Enzyme Induction Assay) utilizes short-term animal experiments to assess inductive capability.

    • Main Results:

    • COMPACT predicts whether a chemical will interact with CYP1A or CYP2E families.
    • The ability of a chemical to induce CYP enzyme levels is a key factor in its carcinogenic potential.
    • ENACT provides a method to determine inductive capability using fewer animals.

    Conclusions:

    • The combination of COMPACT and ENACT offers a rapid, inexpensive preliminary screening for chemical carcinogenicity.
    • This approach can help prioritize chemicals for further, more extensive testing.
    • Reduces reliance on long-term, costly rodent bioassays for initial assessment.